BARCLAYS PLC - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,236
+154.1%
244,266
+165.3%
0.00%
+200.0%
Q2 2023$1,667
+430.9%
92,076
+681.6%
0.00%
Q1 2023$314
-38.7%
11,781
-55.6%
0.00%
Q4 2022$512
-99.6%
26,515
+373.8%
0.00%
Q3 2022$117,000
+25.8%
5,596
-51.8%
0.00%
Q2 2022$93,000
-14.7%
11,609
-25.0%
0.00%
Q1 2022$109,00015,4830.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 339,160$5,881,034100.00%
CHI Advisors LLC 3,014,199$52,266,21120.72%
TRV GP IV, LLC 2,132,867$36,983,91413.93%
GREAT POINT PARTNERS LLC 1,755,184$30,434,8915.54%
First Light Asset Management, LLC 2,933,260$50,862,7284.83%
Deep Track Capital, LP 5,500,000$95,370,0003.68%
Casdin Capital, LLC 1,577,108$27,347,0533.03%
Fernwood Investment Management, LLC 379,702$6,584,0332.37%
Redmile Group, LLC 2,678,099$46,438,2372.21%
SILVERARC CAPITAL MANAGEMENT, LLC 250,409$4,342,0921.32%
View complete list of PLIANT THERAPEUTICS INC shareholders